Go to deals
Healthcare

MediPress Health – Limited Partnership has completed an IPO

MediPress Health – Limited Partnership has completed a fundraising to refinance and develop the business.

The venture MediPress Health – Limited Partnership is a public R&D life science partnership that invests in medical R&D companies specialized in digital and advanced breakthrough technologies. The venture is managed by an accomplished team with proven experience and an innovative team from the medical, technology and investments industry.

Oaklins’ team in Israel advised the company and acted as the leader of the distributors’ consortium.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Ruben  Eblagon

Ruben Eblagon

Principal
Tel Aviv, Israel
Oaklins Rosario
 Boaz  Levi

Boaz Levi

Partner
Tel Aviv, Israel
Oaklins Rosario

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination
Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more
Agar Scientific has been acquired by Calibre Scientific
Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more
Cooper Consumer Health has sold Stardea to EA Pharma
Private Equity | Healthcare

Cooper Consumer Health has sold Stardea to EA Pharma

Cooper Consumer Health has sold Stardea to EA Pharma.

Learn more